Research projects

Emanuele Azzoni and Team in the lab

Active Italy

Leukaemia

What causes JMML – a rare childhood blood cancer?

JMML (Juvenile myelomonocytic leukaemia) affects very young children and is hard to treat, so this project is looking at what causes it to try to find new cures.

Researcher: Dr Emanuele Azzoni

Pursuing new clues about the cause of a rare childhood blood cancer
Nicolas Alcala and Team

Active France

Lung cancer

How does a rare but incurable cancer type develop?

Discovering more about how mesothelioma cells behave could reveal clues about how to better diagnose or prevent this aggressive type of cancer.

Researcher: Dr Nicolas Alcala

Discovering if mesothelioma cells compete or cooperate
Gertraud Orend in her lab

Active France

General cancer research

Could a new molecular tool improve the effectiveness of radiotherapy?

For some patients, cancer can return after successful radiotherapy treatment. This project aims to discover new information about how we could reduce this chance.

Researcher: Dr Gertraud Orend

Could a new molecular tool improve the effectiveness of radiotherapy?
Roberta Tasso Headshot

Active Italy

General cancer research

Could nanoparticle 'smart bombs' target hard-to-treat tumours?

Once cancer has spread, or metastasised, it often becomes incurable. This project is investigating new ways to deliver drugs specifically to metastatic tumours.

Researcher: Professor Roberta Tasso

Developing natural nanoparticle “smart bombs” to target hard-to-treat tumours
Daniele Fachinetti and Team

Active France

General cancer research

Can we find new druggable targets for cancer treatments?

By understanding the link between structures in our cells called 'centromeres' and cancer development, this team aim to find possible new ways to target cancer.

Researcher: Dr Daniele Fachinetti

Breaking point: causes and consequences of ‘centromere breakage’ in cancer development
Ylli Doksani and Team

Active Italy

General cancer research

What's the connection between chemotherapy and chromosomes?

Chemotherapy is one of the most common cancer treatments but it doesn't work for everyone so this team want to understand why so they can make it more successful. 

Researcher: Dr Ylli Doksani

Chemotherapy and chromosomes: understanding the connection
Pierre Val and Team

Active France

General cancer research

Could testosterone be used to treat a very rare cancer?

Adrenocortical cancer is rare and aggressive, with limited treatments. These researchers have found exciting signs that testosterone could help slow its growth. 

Researcher: Dr Pierre Val

Could testosterone be used to treat a very rare cancer?
Niall Kenneth Team

Active United Kingdom

Lung cancer

Can we “suffocate” lung cancer in low oxygen environments?

This project hopes to new ways to target cancer without affecting healthy tissue, leading to kinder and groundbreaking cures for lung cancer and mesothelioma.

Researcher: Dr Niall Kenneth

Suffocating tumours: can we stop cancer from growing in low oxygen environments?
Hector Peinado Selgas and Team

Active Spain

Breast cancer

What is the link between obesity and breast cancer spreading?

Obesity makes it easier for breast cancer to spread but this project will try to find out why to hopefully reveal new ways to stop breast cancer spreading.

Researcher: Dr Hector Peinado Selgas

Shining a light on the link between obesity and breast cancer’s ability to spread